China Health Industries Holdings, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2019
May 15, 2019 at 10:51 am EDT
Share
China Health Industries Holdings, Inc. announced earnings results for the third quarter ended March 31, 2019. For the third quarter, the company announced sales was USD 2.202 million compared to USD 1.538 million a year ago. Operating income was USD 1.066 million compared to operating loss of USD 286,355 a year ago. Net income was USD 767,929 compared to USD 10,711 a year ago. Basic earnings per share from continuing operations was USD 0.012 compared to USD 0.0002 a year ago. Diluted earnings per share from continuing operations was USD 0.0117 compared to USD 0.0002 a year ago. For the nine months, sales was USD 7.058 million compared to USD 4.863 million a year ago. Operating income was USD 3.456 million compared to operating loss of USD 486,120 a year ago. Net income was USD 2.517 million compared to net loss of USD 279,032 a year ago. Basic earnings per share from continuing operations was USD 0.038 compared to basic loss per share from continuing operations of USD 0.004 a year ago. Diluted earnings per share from continuing operations was USD 0.0384 compared to diluted loss per share from continuing operations of USD 0.0043 a year ago.
China Health Industries Holdings, Inc. is a manufacturer of health food products. The Company's principal business operations are conducted through its subsidiaries: Harbin Humankind Biology Technology Co., Limited (Humankind) and Heilongjiang Huimeijia Pharmaceutical Co., Ltd (HLJ Huimeijia). The Company has three operating segments: Humankind, HLJ Huimeijia and others. Humankind is engaged in the manufacturing and sale of health products. HLJ Huimeijia is engaged in the manufacturing and distribution of tincture; ointments; rubber paste, including hormones; topical solution, suppositories, liniment, including traditional Chinese medicine extractions; enemas, and oral liquids. As of June 30, 2016, the Company, through Humankind manufactured and sold 14 health supplement products. As of June 30, 2016, the Company, through HLJ Huimeijia manufactured and sold 21 products. The Company's products are sold through sales agents.
CHINA HEALTH INDUSTRIES HOLDINGS, INC. 